Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvanted H1N1 Vaccine in HIV-Infected Adults
NCT01155037Phase 2Completed
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Mar 2010
- Primary completion
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza (3 arms), sponsored by Fundação Oswaldo Cruz. Primary endpoints: Proportions of seroconversion, Proportions of seroprotection and 1 more. Started Mar 2010; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01155037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155037.